OMV Aktiengesellschaft’s €1 Billion Notes Offering

White & Case LLP has advised multiple Joint Lead Managers on a €1 billion bond issue by OMV Aktiengesellschaft. The Joint Lead Managers were Citigroup Global Markets Limited, Crédit Agricole Corporate and Investment Bank, DZ BANK Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main, Raiffeisen Bank International AG and SMBC Nikko Capital Markets Limited. OMV AG explores and […]

Hasbro Inc.’s $1.1 Billion Revolving Credit Facility

Shearman & Sterling advised Bank of America, N.A., as administrative agent, on a $1.1 billion unsecured revolving credit facility for Hasbro Inc. that amends and restates its existing unsecured revolving credit facility. Hasbro Inc., headquartered in Pawtucket, Rhode Island, operates as a play and entertainment company that specializes in children’s toys. Shearman advised Bank of […]

Jawa 1 LNG-to-Power Project’s $1.7 Billion Financing

Shearman & Sterling advised a consortium led by Pertamina Power Indonesia, Marubeni Corporation and Sojitz Corporation in connection with the development and financing of the US$1.7 billion integrated LNG-to-power project located in West Java Province, Indonesia. The project achieved financial close on December 5, 2018. This transaction represents the first-ever LNG-to-power project in the Asia […]

GlaxoSmithKline plc’s World-Leading Consumer Healthcare Joint Venture With Pfizer plc

Centerview Partners LLC, Guggenheim Securities, LLC and Morgan Stanley & Co. LLC served as Pfizer’s financial advisors, Wachtell, Lipton, Rosen & Katz, and Clifford Chance LLP served as its legal advisors, and Skadden, Arps, Slate, Meagher & Flom LLP served as its tax advisor. Kirkland & Ellis LLP and Slaughter and May advised GlaxoSmithKline plc […]

Bristol-Myers Squibb’s $74 Billion Acquisition of Celgene Corporation

Morgan Stanley & Co. LLC is serving as lead financial advisor to Bristol-Myers Squibb, and Evercore and Dyal Co. LLC are serving as financial advisors to Bristol-Myers Squibb. Kirkland & Ellis LLP is serving as Bristol-Myers Squibb’s legal counsel. J.P. Morgan Securities LLC is serving as lead financial advisor and Citi is acting as financial […]

Consolidated Edison Company of New York, Inc.’s $1.1 Billion Notes Offering

Hunton Andrews Kurth LLP advised the underwriters on an SEC-registered offering by Consolidated Edison Company of New York, Inc. (CECONY) of $500 million aggregate principal amount of debentures due 2028 and $600 million aggregate principal amount of debentures due 2048. BofA Merrill Lynch, Mizuho Securities, MUFG, Scotiabank, Wells Fargo Securities, CIBC Capital Markets, KeyBanc Capital […]

Scholar Rock and Gilead Enter’s $1.5 Billion Collaboration with Deal

Goodwin advised Scholar Rock on its strategic collaboration with Gilead Sciences to discover and develop highly specific inhibitors of transforming growth factor beta (TGFβ) activation for the treatment of fibrotic diseases. Gilead Sciences, Inc. (NASDAQ: GILD) and Scholar Rock Holding Corporation (NASDAQ: SRRK) have entered into a strategic collaboration to discover and develop highly specific […]

Hologic, Inc. $3 Billion Senior Secured Credit Facilities Refinancing

Davis Polk advised the administrative agent and the lenders in connection with the refinancing of Hologic, Inc.’s existing senior secured credit facilities with a $1.5 billion term loan facility and a $1.5 billion revolving credit facility, the proceeds of which will be used to consummate the refinancing and for working capital and other permitted purposes. […]

GLP’s €2 Billion Partnership

Kirkland & Ellis LLP advised GLP, the leading global provider of modern logistics facilities and technology-led solutions, in establishing GLP Continental Europe Development Partners I (“GLP CDP I”). GLP, the leading global provider of modern logistics facilities and technology-led solutions, will partner with QuadReal Property Group and Canada Pension Plan Investment Board, through its wholly-owned […]